Informations:
Erreur:
ID
29471
Description
Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment; ODM derived from: https://clinicaltrials.gov/show/NCT00881439
Lien
https://clinicaltrials.gov/show/NCT00881439
Mots-clés
Versions (1)
- 29/03/2018 29/03/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
29 mars 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Heart Failure NCT00881439
Eligibility Heart Failure NCT00881439
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT00881439
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Heart failure New York Heart Association Classification
Item
nyha ii-iv heart failure
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Left ventricular ejection fraction
Item
left ventricular ejection fraction < 45%
boolean
C0428772 (UMLS CUI [1])
Pharmaceutical Preparations Stable Heart failure
Item
stable heart failure medication
boolean
C0013227 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
GFR estimation by MDRD
Item
egfr by smdrd formula between 30 and 60 ml/min/1.73m2
boolean
C2170215 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Angiotensin-converting-enzyme inhibitor allergy
Item
known hypersensitivity to study drug or acei
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0571939 (UMLS CUI [2])
C0013230 (UMLS CUI [1,2])
C0571939 (UMLS CUI [2])
Angiotensin II receptor antagonist | Mineralocorticoid Receptor Antagonists
Item
concomitant treatment with both arb and aldosterone receptor antagonist
boolean
C0521942 (UMLS CUI [1])
C1579268 (UMLS CUI [2])
C1579268 (UMLS CUI [2])
Hypotension symptomatic
Item
symptomatic hypotension
boolean
C0863113 (UMLS CUI [1])
Acute heart failure
Item
acute heart failure
boolean
C0264714 (UMLS CUI [1])
Cerebrovascular accident | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Angioplasty
Item
history of stroke, acute coronary syndrome, pci or angioplasty within past 3 months
boolean
C0038454 (UMLS CUI [1])
C0948089 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C0162577 (UMLS CUI [4])
C0948089 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C0162577 (UMLS CUI [4])
Serum potassium measurement
Item
serum potassium > 5.2 mmol/l
boolean
C0302353 (UMLS CUI [1])
Right Heart Failure Due to Lung disease Severe
Item
right heart failure due to severe pulmonary disease
boolean
C0235527 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
C0678226 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])